Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Progressive Supranuclear Palsy Clinical Trial Platform - Regimen A: AADvac1

NCT07217665 is registered in ClinicalTrials.gov with Adam Boxer as lead sponsor.

NCT NCT07217665
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07217665 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Progressive Supranuclear Palsy Clinical Trial Platform - Regimen A: AADvac1
Lead sponsor
Adam Boxer
Phase
Phase 2
Overall status
Enrolling by invitation
Start date
July 29, 2026
Completion date
September 28, 2030
Enrollment
146 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

psp - progressive supranuclear palsy